The study explored the pharmacological properties of Rb1 and revealed that Rb1 could be an important candidate molecule in the prevention and treatment of disorders associated with stress, including depression, exerting considerable effects and relatively few adverse effects. Here, RB1 is linked to depressive symptom measurement.